The Barts Life Sciences Cluster has received government support as part of a national initiative to accelerate health innovation and unlock billions in growth. Speaking at London Life Sciences Week, Dr Zubir Ahmed MP, Parliamentary Under-Secretary of State for Health Innovation and Safety, highlighted that the Barts Life Sciences Cluster stands as a powerful testament to the city’s dynamic energy,...
With planned investment of over £800m, the Cluster brings together Barts Health NHS Trust and private investors to unite clinical excellence and commercial innovation. Science Minister Lord Vallance said: “We have ambitious goals for making the UK Europe’s leader when it comes to life sciences’ sector-led investment in R&D, access to scale-up finance, and pulling in foreign direct investment....
Aimed at college students (16+) and adults in the early stages of their Life Sciences career journeys, this event is your chance to explore career opportunities, meet industry experts, and take part in hands-on activities that bring science to life. If you are an employer, we invite you to showcase your achievements and engage with future talent. Why Attend as...
Cancer remains one of the world’s most complex health challenges, but in East London, collaboration is accelerating progress. The Barts Cancer Institute, based at Queen Mary University of London, is home to world-leading research in cancer biology and treatment. Within it, the Centre for Experimental Cancer Medicine – jointly embedded in Queen Mary and Barts Health NHS Trust – is...
Barts Health NHS Trust has signed a new Memorandum of Understanding (MoU) with the Association of British HealthTech Industries (ABHI) to drive the adoption of cutting-edge health technologies that improve care, reduce health inequalities, and empower clinical teams. This collaboration aims to build a stronger health innovation cluster by bringing industry, academia, and frontline clinicians together to co-develop and scale...
Clinical trials often lack diversity with ethnic minorities being underrepresented. This imbalance can lead to treatments that are less effective for certain populations, reinforcing existing health inequalities. Caring for a population of around 2.5 million people representing 97 nations, Barts Health NHS Trust is well positioned to change this. Barts Health is already routinely capturing the diversity of research participants...
Life sciences work doesn’t just happen in the lab. Barts Life Sciences has published a career pathways map, detailing the different ways to enter into a career in life sciences and the variety of careers available. The map can be downloaded here: Life Science Career Pathways Watch this space for details of new Barts Life Sciences’ skills and training initiatives...
Hiba Junaid, Data Scientist at Barts Life Sciences and Suthesh Sivapalaratnam, Consultant Haematologist at Barts Health, spoke at the Barts Health flagship event celebrating International Clinical Trials Day and its contribution to detecting rare diseases through the use of AI. Rare diseases affect over 3.5 million people in the UK alone, yet it can take nearly 5 years on average...
In the UK, millions of people are affected by blood disorders. These range from common conditions like anaemia to life-threatening diseases such as leukaemia and lymphoma, with over 41,000 people diagnosed with blood cancer each year.1 Providing a fast and accurate diagnosis for these disorders is essential to ensure timely treatment and improve patient outcomes. However, the diagnosis is a...
We are celebrating International Clinical Trials Day to highlight the groundbreaking work being done across Barts Health and Queen Mary University of London. The clinical research landscape in the UK brims with opportunity and innovation, and offers significant return on investment. We spoke with Jenny Rivers, Director of Research & Development at Barts Health NHS Trust and Academy of Medical Sciences...
Accessibility options
Translate the page